Foundayo is FDA-approved for: Weight loss in adults with obesity or overweight with at least one weight-related health condition (such as type 2 diabetes) One of the key differentiators for Foundayo is its administration: It is the only GLP-1 pill for weight loss that can be taken any time of day, with or without food
This, in turn, will affect the packaging, logistics, supply chain, and other support industries for the junk food industry
The BPC-157 peptide is used in research on tissue healing, especially in tendon, ligament, muscle, and gut injuries
(Subject to change per Eli Lilly
Its shorter half-life of 13 hours necessitates daily administration but allows for more rapid dose adjustments